Drug profile · INN
beclomethasone dipropionate monohydrate
VANCENASE AQ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
beclomethasone dipropionate monohydrate (VANCENASE AQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.
Key facts
INN beclomethasone dipropionate monohydrate
Brand VANCENASE AQ
Route NASAL
Formulation SPRAY, METERED
Frequently asked questions
What is beclomethasone dipropionate monohydrate?
beclomethasone dipropionate monohydrate (VANCENASE AQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for beclomethasone dipropionate monohydrate?
VANCENASE AQ is a marketed brand name for beclomethasone dipropionate monohydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of beclomethasone dipropionate monohydrate?
beclomethasone dipropionate monohydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.